Research Beyond Borders Partnering Research Beyond Borders Partnering Our Research Beyond Borders team is looking for emerging science and technology opportunities. Learn more about partnering with us.
Generalized pustular psoriasis: Unmet needs Generalized pustular psoriasis: Unmet needs Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the impact of living with GPP including unseen challenges and future management.
collaboration-proxygen-molecular-glue-degraders collaboration-proxygen-molecular-glue-degraders Boehringer Ingelheim collaborates with Proxygen to explore molecular glue degraders – a novel approach to fight cancer.
10 things you should know about rabies 10 things you should know about rabies 10 things you should know about rabies
Research ruminant animal health well-being Research ruminant animal health well-being Boehringer Ingelheim supports young scientists and veterinarians dedicated to ruminant health research
Mastitis dairy cows prevent antibiotic resistance Mastitis dairy cows prevent antibiotic resistance The Clinical and Laboratory Standards Institute (CLSI) approved revised interpretive criteria for the susceptibility testing of a mastitis product.
Implementing the generalized pustular psoriasis (GPP) Charter Implementing the generalized pustular psoriasis (GPP) Charter Read more about the projects are implementing the generalized pustular psoriasis (GPP) Charter
Reduction of Salmonella in swine after vaccination Reduction of Salmonella in swine after vaccination Authorities acknowledge reduction of Salmonella after vaccination with Enterisol® Ileitis
Boehringer Ingelheim partners with PetMedix Boehringer Ingelheim partners with PetMedix Partnering with PetMedix on Ky9™ platform cutting edge technology as a means to bring innovative new therapies to improve health of animals
Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award Winners of the 2020 European PRRS Research Award announced Three winner awarded 25,000 euro each for their research.
EMA authorization for Reprocyc ParvoFLEX EMA authorization for Reprocyc ParvoFLEX Boehringer Ingelheim obtains EMA authorization for Reprocyc® ParvoFLEX, a new porcine parvovirus vaccine
FRONTLINE becomes Brand of the Year 2019-2020 FRONTLINE becomes Brand of the Year 2019-2020 FRONTLINE becomes ‘Brand of the Year’ 2019-2020 in World Branding Awards
garbage game garbage game Learn more about marine pollution and find out how long it takes for garbage to dissolve in the oceans.
World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination World Rabies Day 2020 sustainable dog vaccination
The GPP Forum Report The GPP Forum Report The generalized pustular psoriasis (GPP) Forum Report summarizes and highlights the important moments form the multistakeholder GPP Forum
Research Beyond Borders overview Research Beyond Borders overview Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
The power of patient advocacy in cancer care The power of patient advocacy in cancer care Larry, a retired US Navy veteran, and Jeff, UICC President, have more in common than a cancer diagnosis: they share a passion for patient empowerment.
Human-dog relationship – a historical perspective Human-dog relationship – a historical perspective The human-dog relationship – a historical perspective
Winners of BVDzero Scholarship Programme Winners of BVDzero Scholarship Programme Boehringer Ingelheim announces winners of BVDzero Scholarship Programme
Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products
Henke-Sass Wolf develop needle free device Henke-Sass Wolf develop needle free device Boehringer Ingelheim partners with Henke-Sass, Wolf to develop innovative needle free injection device for pigs
Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards Winners of 2020 BVDzero Case Awards announced. 10 top clinical cases will receive a total prize of 15,000 euros.
Approval for Aservo EquiHaler equine asthma therapy Approval for Aservo EquiHaler equine asthma therapy Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first equine asthma therapy
Boehringer Ingelheim acquires Global Stem cell Technology Boehringer Ingelheim acquires Global Stem cell Technology Boehringer Ingelheim acquires Global Stem cell Technology, Belgian veterinary biotech company, to strengthen its stem cell capabilities in Animal Health
Cardio-Renal-Metabolic Research Cardio-Renal-Metabolic Research Read about our patient-centric approach to cardio-renal-metabolic disease research.